Blackstone and TPG Plan Major Sale of Hologic Business Unit: What It Means for Traders
Blackstone and TPG seek over $4B for a Hologic business unit, signaling a strong appetite in the healthcare sector.
Dimensional Fund Advisors Increases Stake in Prologis: What It Means for REIT Investors
Dimensional Fund Advisors recently increased its stake in Prologis. What does this mean for REIT investors amid current macroeconomic condit…
Axia's C$1.23B Bid for Plaza Retail REIT: Implications for Canadian Real Estate
Axia's C$1.23 billion bid for Plaza Retail REIT signals a pivotal moment in the Canadian real estate market amidst rising interest rates.
Orezone Gold Issues 2026 Production Guidance: What It Means for Investors
Orezone Gold's 2026 production guidance sheds light on its Casa Berardi Mine amid fluctuating gold prices.
Lime's $1.7 Billion Nasdaq Debut: A New Era for Micromobility IPOs
Lime's IPO at $1.7 billion and Uber's backing signal a pivotal moment for micromobility stocks.
Onex Partners Acquires AirSprint: Insights into Canadian Private Equity Trends
Onex Partners' acquisition of AirSprint signals a robust M&A landscape in Canada, positioning the fractional jet ownership leader for growth…
Equinox Gold's Upcoming Shareholder Vote: Key Insights for Traders
Equinox Gold's shareholder vote on acquiring Orla Mining is set for July 22, creating notable trading opportunities.
Bristow Group Expands Aviation Footprint with $105M Acquisition of Berry Aviation
Bristow Group's $105M acquisition of Berry Aviation signals a strategic move in the defense aviation sector.
California's IPO Tax Windfall: Promises and Pitfalls Ahead
California anticipates a tax windfall from major upcoming IPOs, but challenges loom that could impact its projections.
Adial Pharmaceuticals' $64 Million Acquisition of Azora: What It Means for Biotech Investors
Adial Pharmaceuticals' acquisition of Azora Therapeutics signals strategic growth in the biotech sector, particularly for ulcerative colitis…
SpaceX IPO: A Major Test for the Market and Investor Sentiment
Investor sentiment is being tested as Wall Street evaluates the SpaceX IPO's market impact.
GSK's $10.6B Nuvalent Play: What Big Pharma's Consolidation Appetite Means for the Market
GlaxoSmithKline's $10.6 billion acquisition of Nuvalent signals continued M&A momentum in pharma, reshaping the competitive landscape.